Dean L Schorno - Net Worth and Insider Trading
Dean L Schorno Net Worth
The estimated net worth of Dean L Schorno is at least $2 Million dollars as of 2024-04-25. Dean L Schorno is the CFO of Genomic Health Inc and owns about 30,673 shares of Genomic Health Inc (GHDX) stock worth over $2 Million. Dean L Schorno is also the EVP & CFO of Rigel Pharmaceuticals Inc and owns about 402,891 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $443,180. Details can be seen in Dean L Schorno's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dean L Schorno has not made any transactions after 2024-02-05 and currently still holds the listed stock(s).
Transaction Summary of Dean L Schorno
Dean L Schorno Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dean L Schorno owns 1 companies in total, including Rigel Pharmaceuticals Inc (RIGL) .
Click here to see the complete history of Dean L Schorno’s form 4 insider trades.
Insider Ownership Summary of Dean L Schorno
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2024-02-05 | EVP & Chief Financial Officer |
Dean L Schorno Latest Holdings Summary
Dean L Schorno currently owns a total of 2 stocks. Among these stocks, Dean L Schorno owns 30,673 shares of Genomic Health Inc (GHDX) as of June 10, 2014, with a value of $2 Million and a weighting of 81.45%. Dean L Schorno also owns 402,891 shares of Rigel Pharmaceuticals Inc (RIGL) as of February 5, 2024, with a value of $443,180 and a weighting of 18.55%.
Latest Holdings of Dean L Schorno
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GHDX | Genomic Health Inc | 2014-06-10 | 30,673 | 63.44 | 1,945,895 |
| RIGL | Rigel Pharmaceuticals Inc | 2024-02-05 | 402,891 | 1.10 | 443,180 |
Holding Weightings of Dean L Schorno
Dean L Schorno Form 4 Trading Tracker
According to the SEC Form 4 filings, Dean L Schorno has made a total of 0 transactions in Genomic Health Inc (GHDX) over the past 5 years. The most-recent trade in Genomic Health Inc is the sale of 4,000 shares on June 10, 2014, which brought Dean L Schorno around $110,480.
According to the SEC Form 4 filings, Dean L Schorno has made a total of 3 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 12,628 shares on February 5, 2024, which brought Dean L Schorno around $14,396.
Insider Trading History of Dean L Schorno
- 1
Dean L Schorno Trading Performance
GuruFocus tracks the stock performance after each of Dean L Schorno's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dean L Schorno is -7.32%. GuruFocus also compares Dean L Schorno's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dean L Schorno within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dean L Schorno's insider trading performs compared to the benchmark.
Performance of Dean L Schorno
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.2 | -7.32 | 12.2 | -11.19 | 33.43 | -0.66 |
| Relative Return to S&P 500(%) | 8.9 | -9.65 | 3.31 | -14.65 | 12.81 | -11.62 |
Dean L Schorno Ownership Network
Ownership Network List of Dean L Schorno
Ownership Network Relation of Dean L Schorno
Dean L Schorno Owned Company Details
What does Rigel Pharmaceuticals Inc do?
Who are the key executives at Rigel Pharmaceuticals Inc?
Dean L Schorno is the EVP & Chief Financial Officer of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include Sr VP of Bus Dev and Com Ops Raul R Rodriguez , EVP & Chief Commercial Officer David A Santos , and EVP & CMO Wolfgang Dummer .
Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary
Over the past 18 months, Dean L Schorno made 2 insider transaction in Rigel Pharmaceuticals Inc (RIGL) with a net sale of 18,017. Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 73,234 shares made by Raul R Rodriguez , a net sale of 19,907 shares made by David A Santos , and a net sale of 5,389 shares made by Wolfgang Dummer .
In summary, during the past 3 months, insiders sold 80,041 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 80,041 shares. During the past 18 months, 116,547 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,547 shares.
Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rigel Pharmaceuticals Inc Insider Transactions
Dean L Schorno Mailing Address
Above is the net worth, insider trading, and ownership report for Dean L Schorno. You might contact Dean L Schorno via mailing address: 301 Penobscot Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
